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Abstract
Monitoring the biomedical literature for
cases of Adverse Drug Reactions (ADRs)
is a critically important and time consum-
ing task in pharmacovigilance. The devel-
opment of computer assisted approaches
to aid this process in different forms has
been the subject of many recent works.
One particular area that has shown
promise is the use of Deep Neural Net-
works, in particular, Convolutional Neu-
ral Networks (CNNs), for the detection
of ADR relevant sentences. Using token-
level convolutions and general purpose
word embeddings, this architecture has
shown good performance relative to more
traditional models as well as Long Short
Term Memory (LSTM) models.
In this work, we evaluate and compare
two different CNN architectures using the
ADE corpus. In addition, we show that
by de-duplicating the ADR relevant sen-
tences, we can greatly reduce overopti-
mism in the classification results. Finally,
we evaluate the use of word embeddings
specifically developed for biomedical text
and show that they lead to a better perfor-
mance in this task.
1 Introduction
Pharmacovigilance is a crucial component at ev-
ery stage of the drug development cycle, and reg-
ulations require pharmaceutical companies to pre-
pare periodic reports such as Development Safety
Update Reports (DSURs) and Periodic Safety Up-
date Reports (PSURs) regarding the safety of their
drugs and products (Krishnamurthy et al., 2017).
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One of the most important sources of informa-
tion to be monitored in pharmacovigilance is the
biomedical literature (Pontes et al., 2014). To this
end, large numbers of scientific abstracts and pub-
lications need to be screened and/or read in full in
order to collect information relevant to safety, and
in particular Adverse Drug Reactions (ADRs) as-
sociated to a particular drug.
Screening and reading the biomedical literature
is a time consuming task and is of critical impor-
tance. It requires particular expertise, and needs to
be performed by well-trained readers. Given this,
systems that enable human readers to perform this
task faster and more effectively would be of great
value.
2 Background
Computer assisted pharmacovigilance and, more
specifically, the automation of the detection of
ADR relevant information across various data
sources has the potential to have great positive im-
pact on the pharmaceutical industry. There is a
very vast array of sources of potential ADR rel-
evant information, including both structured and
unstructured data resources.
In many cases, adverse reactions are initially de-
tected through unstructured means of communica-
tion, such as a patient speaking to a healthcare pro-
fessional, and case reports written by physicians
and published in biomedical literature sources,
such as MEDLINE, PubMed and EMBASE (Ri-
son, 2013). Spontaneous reporting can also be
made through telephone calls, email communica-
tion, and even fax (Vallano et al., 2005). Such in-
formation is processed, generally through human
intervention in order to properly categorize them
and add the necessary metadata.
Other potential sources of safety signals include
electronic medical/health records (EMRs/EHRs)
(Park et al., 2011). Similarly, omics, chemical,
phenotypic and metabolic pathway data can be an-
alyzed using a diverse array of methods to find as-
sociations between drugs and specific side effects
(Liu et al., 2012; Mizutani et al., 2012; Lee et al.,
2011). In recent years, social media websites have
also become a potential source of safety signals
(Karimi et al., 2015; Sarker and Gonzalez, 2015;
Tafti et al., 2017).
Finally, after careful processing, the data is usu-
ally aggregated and stored in structured databases
for reporting and/or aggregation. Many regula-
tory agencies maintain databases that aggregate
information regarding reported adverse events,
such as the FDA Adverse Event Reporting Sys-
tem (FAERS) (Fang et al., 2014) in the U.S., Eu-
draVigilance in Europe (Banovac et al., 2017), and
the MedEffect Adverse Reaction Online Database
in Canada (Barry et al., 2014).
The aim of our work is to contribute towards the
development of systems that provide assistance to
readers in charge of finding ADR signals in the
biomedical literature. As such, the ideal system
should be able to accurately discriminate between
ADR relevant and irrelevant sentences in the doc-
uments that it processes.
In the following section, we detail some of the
past efforts to automate this as well as other tasks
related to the extraction of ADR relevant informa-
tion from the biomedical literature.
3 Related Work
The automation of the detection of ADR relevant
information across various data sources has re-
ceived much attention in recent years. Ho et al.
performed a systematic review and summarized
their findings on various methods to predict ADEs
ranging from omics to social media (Ho et al.,
2016). In addition, the authors presented a list
of public and commercial data sources available
for the task. Similarly, Tan et al. summarized the
available data resources and presented the state of
computational decision support systems for ADRs
(Tan et al., 2016). Harpaz et al. prepared an
overview of the state of the art in text mining
for Adverse Drug Events (ADEs) (Harpaz et al.,
2014) in various contexts, such as the biomedical
literature, product labelling, social media and web
search logs.
Xu et al. initially proposed a method based on
manually curated lexicons which could be used
to build cancer drug-side effect (drug SE) pair
knowledge bases from scientific publications (Xu
and Wang, 2014c). The authors also described a
method to extract syntactical patterns, via parse
trees from the Stanford Parser (Xu and Wang,
2014a), based on known seed cancer drug-SE
pairs. The patterns can then be used to extract new
cancer drug-SE pairs. They further proposed an
approach using SVM classifiers to categorize ta-
bles from cancer related literature as either ADR
relevant or not (Xu and Wang, 2015a). The au-
thors then extracted cancer drug-SE pairs from the
tables using a lexicon-based approach and com-
pared them with data from the FDA label infor-
mation. Xu et al. also evaluated their method in
a large scale, full text corpus of oncological pub-
lications (Xu and Wang, 2015b), extracting drug-
SE pairs and showing good correlation of the ex-
tracted pairs with gene targets and disease indica-
tions.
There are a number of available data resources
for the purpose of ADR signal detection. Gu-
rulingappa et al. introduced the ADE corpus, a
large corpus of MEDLINE sentences annotated as
ADR relevant or not (Gurulingappa et al., 2012).
Karimi et al. described CADEC, a corpus of so-
cial media posts with ADE annotations (Karimi
et al., 2015) including mappings to vocabularies
such as SNOMED. Further, the annotations in-
clude detailed information such as drug-event and
drug-dose relationships. Sarker et al. described an
approach using SVM classifiers, as well as diverse
feature engineering methods, to classify clinical
reports and social media posts from multiple cor-
pora as ADR relevant or not (Sarker and Gonza-
lez, 2015). Odom et al. explored an approach
using relational gradient boosting (FRGB) models
to combine information learned from labelled data
with advice from human readers in the identifica-
tion of ADRs in the biomedical literature (Odom
et al., 2015). Adams et al. proposed an approach
using custom search PubMed queries making use
of MeSH subheadings to automatically identify
ADR related publications. The authors conducted
an evaluation by comparing with results manually
tagged by investigators, obtaining a precision of
0.90 and a recall of 0.93.
Some researchers have tried to combine infor-
mation from structured databases with the unstruc-
tured data found in the biomedical literature. For
example, Xu et al. showed that, by combining in-
formation from FAERS and MEDLINE using sig-
nal boosting and ranking algorithms, it’s possible
to improve cancer drug-side effect (drug-SE pair)
signal detection (Xu and Wang, 2014b).
There have recently been efforts to use neu-
ral networks to improve the performance of the
ADR sentence detection, entity and relation ex-
traction tasks. Gupta et al. proposed a two step ap-
proach for extracting mentions of adverse events
from social media: (1) predicting the drug based
on the context, unsupervised; (2) predicting ad-
verse event mentions based on a tweet and the
features learned in the previous step, supervised
(Gupta et al., 2017). Li et al. proposed ap-
proaches combining CNNs and bi-LSTMS to per-
form named entity recognition as well as relation
extraction for ADRs in the annotated sentences in
the ADE dataset (Li et al., 2017). More recently,
Ramamoorthy et al. described an approach us-
ing bi-LSTMs with an attentional mechanism to
jointly perform relation extraction as well as visu-
alize the patterns in the sentence.
Huynh proposed using convolutional recurrent
neural networks (CRNN) and convolutional neu-
ral networks with attention (CNNA) to identify
ADR related tweets and MEDLINE article sen-
tences (Huynh et al., 2016). The CNNA’s atten-
tion component had the attractive property that it
allows visualization of the influence of each word
in the decision of the network.
In this work, we introduce approaches building
upon previous results using convolutional neural
networks (CNNs) (Huynh et al., 2016) to detect
ADR relevant sentences in the biomedical litera-
ture. Our key contributions are as follows:
• We compare Huynh’s CNN approach, which
is based on the architecture proposed by Kim
(2014), with a deeper architecture based on
the one proposed by Hughes et al. (2017), us-
ing the ADE dataset, showing that Kim’s ar-
chitecture performs much better for this task
and dataset.
• We apply a de-duplication of the ADR rele-
vant sentences in the ADE dataset, (Gurulin-
gappa et al., 2012) which we believe leads to
a better estimation of the performance of the
algorithm and does not seem to be applied in
some of the previous works.
• We evaluate the use of word embeddings de-
veloped specifically for biomedical text in-
troduced by Pyysalo et al. (2013) and show
that, by using these embeddings in place of
general-purpose GloVe embeddings, it is pos-
sible to improve the performance of the algo-
rithm.
4 Dataset
The ADE corpus was introduced by Gurulingappa
et al. (2012) in order to provide a benchmark
dataset for the development of algorithms for the
detection of ADRs in case reports. The original
source of the data was 2972 MEDLINE case re-
ports. The data was labelled by three trained an-
notators and their annotation results were consoli-
dated into a final dataset including 6728 ADE re-
lations (in 4272 sentences), as well as 16688 non-
ADR relevant sentences.
The authors calculated Inter-Annotator Agree-
ment (IAA), using F1 scores as a criterion, for
adverse event entities between 0.77 and 0.80 for
partial matches and between 0.63 and 0.72 for ex-
act matches. For more detail, the reader can refer
to the work of Gurulingappa et al. (Gurulingappa
et al., 2012).
4.1 Preprocessing
The dataset is suitable for two types of tasks: (1)
categorization of sentences as either relevant for
ADRs or not; and (2) extraction of drug-adverse
event relations and drug-dose relations. Because
there can be more than one relation in the same
sentence, the ADR relevant sentences are some-
times duplicated.
The presence of duplicates can lead to situa-
tions where the same sentence is present in both
the training and test datasets, as well as to an over-
all distortion of the distribution of the sentences.
In order to prevent this, we de-duplicate these sen-
tences, which results in 4272 ADR relevant sen-
tences, as stated in the work of Gurulingappa et
al. (Gurulingappa et al., 2012).
5 Methods
In the following sections, we will describe (1) the
word embeddings used in our learning algorithms;
and (2) the two different CNN architectures eval-
uated in our experiments.
5.1 Embeddings
GloVe 840B
As in Huynh’s work (Huynh et al., 2016), we
use pre-trained word embeddings. Huynh focused
mainly on the general purpose GloVe Common
Crawl 840B, 300 dimensional word embeddings
(Pennington et al., 2014).
Pyysalo’s Embeddings
We also evaluate the use of 200 dimensional
word2vec embeddings introduced by Pyysalo et
al. (Pyysalo et al., 2013). These word embeddings
were fitted on a corpus combining PubMed ab-
stracts, PubMed Central Open Access (PMC OA)
full text articles as well as Wikipedia articles. We
also initialize zero valued vectors for the unknown
word symbol as well as for the padding symbol.
Preprocessing
As in Huynh’s work, no new word vectors are ini-
tialized for tokens not present in the pre-trained
vocabulary, and only the tokens that are in the
20000 most frequent words in the dataset are in-
cluded. The remaining tokens are mapped to the
unknown word symbol vector. We enable the algo-
rithm to optimize the pre-trained weights after ini-
tialization. We follow the preprocessing strategy
used by Huynh (Huynh et al., 2016), which is itself
based on that of Kim (Kim, 2014), and includes
expansion of contractions, and additionally, all
non-alphabetic characters are replaced with spaces
prior to tokenization.
6 Convolutional Neural Network
Architectures
In all architectures described below, the sentences
are mapped to a vector representation, v. Dropout
is applied to v during training with a dropout prob-
ability of 0.5. As in usual classification tasks, the
predicted probability of a possitive outcome, that
is, of the sentence being ADR relevant, is given by
yˆ = ρ
(
v
T
w + b
)
, (1)
where w is a vector of coefficients, b is the in-
tercept, and ρ is the sigmoid function.
The objective function to be optimized is the
cross entropy, which can also be interpreted as an
average negative log-likelihood, and is given by
Figure 1: Diagram of the architecture proposed by
Huynh (Huynh et al., 2016).
L
(
Θ
)
= −
1
N
[ N∑
i=1
yilog
(
yˆi
)
+
(1− yi)log
(
1− yˆi
)]
. (2)
Huynh’s CNN architecture
This architecture consists of the use of a 1D-
convolution layer with 300 filters and a 5 token
window applied on the word vectors. This is fol-
lowed by a Rectified Linear Unit (ReLu) and a 1D-
max pooling over the full axis of 1D-convolution
results. This leads to a 300 dimensional vector
representation, v, which is used as an input for
the classification network described above. Fig-
ure 1 shows a diagram of the resulting architec-
ture. Note that M , the number of embedding di-
mensions, may be equal to either 300 or 200, but
is shown as 300 for illustration in the figure.
To reduce overfitting, a constraint is added to
ensure that the L2 norms of each one of the 1D
convolution filters are never above a threshold
value, s, after each batch. For more detail, the
reader can refer the works of Huynh (Huynh et al.,
2016) and Kim (Kim, 2014).
Hughes’ CNN architecture
Based on the approach proposed by Hughes
(Hughes et al., 2017) we explored a deeper ar-
chitecture, with multiple successive stages of 1D-
convolution, non-linear transformations, and max
pooling.
This architecture starts with two successive
stages of 1D-convolutions with 256 filters and a 5
Figure 2: Diagram of an architecture based on the
one proposed by Hughes (Hughes et al., 2017).
token window, each followed by a ReLu transfor-
mation. After this, a 1D-max pooling on the axis
of the convolutions with a window of length 5 is
applied. Finally, another two successive stages of
1D-convolutions with 256 filters and a window of
length 5, each followed by a ReLu transformation,
is applied, followed by a 1D-max pooling over the
full axis of the 1D-convolutions.
Similar to the case of the previous architecture,
this leads to a 256 dimensional vector represen-
tation, v, and a constraint is used to keep the L2
norms of all 1D-convolution filters under a thresh-
old value s. Figure 2 shows a diagram of the re-
sulting architecture. As previously, note that M
may be equal to either 300 or 200, but is shown as
300 for illustration in the figure.
For further detail, the reader can refer to the
work of Hughes (2017).
7 Experimental Setup
Following the approach used by Huynh et al.
(2016), we used 10-fold cross validation to eval-
uate the performance of our classifiers. The nor-
malization threshold used to clip the L2 norms of
the filters, s, was set to 9.
The Adam optimizer (Kingma and Ba, 2014)
was used to minimize the loss, L
(
Θ
)
, with 8
epochs and a batch size of 50. To avoid overfit-
ting, early stopping is used based on a develop-
ment set consisting of 10% of the training data of
each fold. For the decision of the classifier, in-
stead of a yˆ threshold of 0.5, we determine the op-
timum threshold by evaluating all possible thresh-
olds present in the development set of each fold
and keeping the threshold that results in the best
F1 score.
After every 10 batches, the optimal threshold is
determined from the development set and the as-
sociated best F1 score is obtained. Optimization is
stopped if the F1 score on the development set fails
to improve after 6 steps. The set of CNN param-
eters associated with the best F1 score observed
throughout the training process is then kept and
used to evaluate the network’s performance on the
test set of each fold.
We use the architecture originally proposed
by Huynh (Huynh et al., 2016) without de-
duplication as the baseline results to understand
the impact of the de-duplication, choice of embed-
dings, and CNN architecture.
All CNN implementations were done using
Python 3.4.5 (Rossum, 1995) and Tensorflow
1.2.0 (Abadi et al., 2015).
8 Results
8.1 Impact of De-duplication on
Classification Performance Estimates
De-duplication No Yes
Accuracy 0.919 0.914
Precision 0.858 0.784
Recall 0.860 0.798
F1-score 0.859 0.790
Specificity 0.942 0.943
AUROC 0.966 0.954
Table 1: Performance metrics of Huynh’s archi-
tecture using GloVe 840B embeddings with and
without de-duplication of the ADR relevant sen-
tences.
Table 8.1 shows a comparison of the perfor-
mance metrics of our implementation of Huynh’s
architecture and GloVe 849B word embeddings
with and without de-duplication of the sentences
labelled as ADR relevant. After de-duplication,
most of the performance metrics were lower, since
the presence of duplicates in the positive samples
resulted in overly optimistic results.
The biggest impact was observed on precision,
recall and F1 scores. Overall accuracies and area
under the ROC curve (AUROC) didn’t seem to be
greatly affected. Note that the specificity, which
is the true negative rate, was higher after de-
duplication.
We initially obtained somewhat lower per-
formances for the baseline model without de-
duplication compared to the one reported by
Huynh et al. (2016) even though we accurately
followed the described architecture. After inves-
tigating the differences in the code, we noticed
that during pre-processing, characters that are not
alphabetic are replaced with spaces prior to tok-
enization. After incorporating this step into our
code, the results matched the previously reported
ones much better.
8.2 Impact of Biomedical Word Embeddings
Word Embeddings Glove 840B Pyysalo
Accuracy 0.914 0.918
Precision 0.784 0.800
Recall 0.798 0.797
F1-score 0.790 0.798
Specificity 0.943 0.949
AUROC 0.954 0.958
Table 2: Performance metrics of Huynh’s archi-
tecture with de-duplication with GloVe 840B em-
beddings and Pyysalo’s embeddings.
Table 8.2 shows a comparison of the per-
formance metrics with de-duplication of ADR
relevant sentences using the GloVe 840B word
embeddings, and the word embeddings fit for
biomedical data purposes proposed by Pyysalo et
al. (Pyysalo et al., 2013).
In most cases, the use of biomedical word em-
beddings was favorable or non-detrimental to the
performance metrics. The largest improvement
was seen on the increase of average precision from
0.780 with GloVe 840B to 0.800 with the biomed-
ical embeddings.
This also led to an increased average F1 score
from 0.790 to 0.798. The average AUROC also in-
creased from 0.954 to 0.958. Specificity increased
from 0.943 to 0.949, and recall was the only metric
that was slightly reduced from 0.798 to 0.797.
8.3 Comparison With Hughes’ CNN
Architecture
Architecture Huynh Hughes
Accuracy 0.918 0.905
Precision 0.800 0.765
Recall 0.797 0.771
F1-score 0.798 0.767
Specificity 0.949 0.939
AUROC 0.958 0.940
Table 3: Performance metrics of Huynh’s and
Hughes’ architectures with de-duplication and
Pyysalo’s embeddings.
Table 8.3 shows a comparison between the per-
formances of our implementations of Huynh’s
and Hughes’ architectures. In both cases, de-
duplication of ADR relevant sentences, and
biomedical embeddings were used. The former
ourperformed the latter in every performance met-
ric. The biggest improvement was in metrics as-
sociated to the positive class, such as precision,
recall, and F1 score.
9 Discussion
The purpose of this work was to evaluate the
use of convolutional neural networks (CNNs) ar-
chitectures and biomedical word embeddings for
the automatic categorization of sentences relevant
to adverse drug reactions (ADRs) in case reports
present in the biomedical literature. For this pur-
pose, we used the ADE corpus, which consists of
sentences coming from 2972 MEDLINE case re-
ports labelled by trained annotators. This includes
4272 ADR relevant sentences, as well as 16688
non-ADR relevant sentences.
We showed that, because of duplications
present in the ADE corpus, the use of this dataset
for sentence classification without performing a
de-duplication can lead to overoptimistic perfor-
mance estimates. In addition, we showed that, by
using biomedical word embeddings, as opposed
to general purpose word embeddings, it’s possi-
ble to improve upon the performance of the al-
gorithm. Finally, we compared the performance
of our implementations of two CNN architectures,
with the architecture proposed by Huynh outper-
forming the architecture proposed by Hughes in
this task and dataset in every metric.
One important measure of the potential noise in
the inputs of human annotators is the Inter Annota-
tor Agreement (IAA) (Gurulingappa et al., 2012),
which in this dataset was measured by its original
authors by calculating inter annotator F1 scores.
Although this measure was calculated on the entity
(partial and exact) matching level, and although
there has been a harmonization process, it is in-
formative of the potential noise in the inputs used
to build the dataset. The fact that the IAAs for
partial matches of adverse events ranged between
0.77 and 0.80 indicates that aiming for near per-
fect predictions may be unrealistic, since there is a
considerable degree of disagreement between hu-
man annotators.
10 Conclusions and Future Work
Our results highlight the importance of sen-
tence de-duplication, pre-processing, choice of
word embeddings, and neural network architec-
tures when applying convolutional neural net-
works (CNNs) for the detection of adverse drug re-
action (ADR) relevant sentences in the biomedical
literature using the ADE dataset. We believe that
these are only a few of the factors that can greatly
influence the performance of the algorithms per-
forming these tasks.
Future work could include the use of either
exhaustive, grid-based or reinforcement-learning
based search for more optimal CNN architectures,
as well as the evaluation of architectures other
than CNNs. In addition, another very interest-
ing area explored in previous works (Huynh et al.,
2016) was the aspect of visualization using CNNs
with Attention (CNNAs). However, this algorithm
seemed to underperform compared to the normal
CNN. Building upon this approach to improve its
performance while retaining its attractive visual-
ization properties would be an important step to-
wards the development of systems that assist hu-
man readers.
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